What is the current share price of GlaxoSmithKline Consumer Healthcare Ltd?
The current share price of GlaxoSmithKline Consumer Healthcare Ltd is ₹ 10,732.60 as of 20 Aug 2020.
What is the market capitalisation of GlaxoSmithKline Consumer Healthcare Ltd?
The market capitalisation of GlaxoSmithKline Consumer Healthcare Ltd stands at -.
What is the PE ratio of GlaxoSmithKline Consumer Healthcare Ltd?
The Price-to-Earnings (PE) ratio of GlaxoSmithKline Consumer Healthcare Ltd is - as of the latest trailing twelve months data.
What is the ROE and ROCE of GlaxoSmithKline Consumer Healthcare Ltd?
GlaxoSmithKline Consumer Healthcare Ltd has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of GlaxoSmithKline Consumer Healthcare Ltd?
The 52-week high of GlaxoSmithKline Consumer Healthcare Ltd is - and the 52-week low is -.
What is the dividend yield of GlaxoSmithKline Consumer Healthcare Ltd?
The dividend yield of GlaxoSmithKline Consumer Healthcare Ltd is 0.98% based on the current market price.
What is the FII and DII holding in GlaxoSmithKline Consumer Healthcare Ltd?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of GlaxoSmithKline Consumer Healthcare Ltd shares.
What sector does GlaxoSmithKline Consumer Healthcare Ltd belong to?
GlaxoSmithKline Consumer Healthcare Ltd operates in the - sector.
What is the beta of GlaxoSmithKline Consumer Healthcare Ltd?
The beta of GlaxoSmithKline Consumer Healthcare Ltd is 0.57, indicating its price volatility relative to the broader market. Over the past 1 year, GlaxoSmithKline Consumer Healthcare Ltd has delivered an absolute return of 34.71%.
What is the RSI of GlaxoSmithKline Consumer Healthcare Ltd?
The 14-day Relative Strength Index (RSI) of GlaxoSmithKline Consumer Healthcare Ltd is 62.66, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.